HIMS three-lens brief
Evidence-based stock research on HIMS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -3.92% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Moved -3.92% yesterday.
- Outperforming SPY by 34.8pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $28.42 — 17% below current (13 analysts).
- Debt-to-equity of 254% — balance-sheet-heavy.
HIMS closed at $34.06 (-3.92%) as of 2026-07-10. Market cap: $7.88B. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 34.8pp over 30 days.. Concerns: moved -3.92% yesterday.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $608.10M, net income -$92.11M, free cash flow $174.31M. Watching for: 2026-08-10 earnings release (30 days out).
Why three lenses on HIMS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine HIMSacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/HIMS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath HIMS brief"></iframe>